The Peptide Therapeutics Market report highlights market opportunities and competitive scenarios for Peptide therapeutics on a regional and global basis. Market size estimation and forecasts have been provided based on a unique research design customized to the dynamics of the Peptide Therapeutics market. The Peptide therapeutics market has been segmented by application (cancer, metabolic, CVD, respiratory, git, anti-infective, dermatology, CNS, renal), route of administration (parenteral, oral), type (innovative, generic), technology (liquid phase, solid phase, hybrid phase), type of molecule (vasopressin, somatostatin, calcitonin, natriuretic, immunopeptide), API peptide type (in-house, CMO). Historic back-drop for the Peptide therapeutics market has been analyzed according to organic and inorganic developments to provide precise market size estimations. Also, key factors impacting the growth of the Peptide Therapeutics market have been identified with potential gravity. Major regions covered in the study include North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World.
Market Segmentation:
By Application:
• Cancer
• Metabolic
• CVD
• Respiratory
• GIT
• Anti-infective
• Dermatology
• CNS
• Renal
By Route of Administration:
• Parenteral
• Oral
By Type:
• Innovative
• Generic
By Technology:
• Liquid Phase
• Solid Phase
• Hybrid Phase
By Type of Molecule:
• Vasopressin
• Somatostatin
• Calcitonin
• Natriuretic
• Immunopeptide
By API Peptide Type:
• In-house
• CMO
By Region:
• North America
◦ North America, by Country
▪ US
▪ Canada
▪ Mexico
◦ North America, by Application
◦ North America, by Route of Administration
◦ North America, by Type
◦ North America, by Technology
◦ North America, by Type of Molecule
◦ North America, by API Peptide Type
• Western Europe
◦ Western Europe, by Country
▪ Germany
▪ UK
▪ France
▪ Italy
▪ Spain
▪ The Netherlands
▪ Rest of Western Europe
◦ Western Europe, by Application
◦ Western Europe, by Route of Administration
◦ Western Europe, by Type
◦ Western Europe, by Technology
◦ Western Europe, by Type of Molecule
◦ Western Europe, by API Peptide Type
• Asia Pacific
◦ Asia Pacific, by Country
▪ China
▪ India
▪ Japan
▪ South Korea
▪ Australia
▪ Indonesia
▪ Rest of Asia Pacific
◦ Asia Pacific, by Application
◦ Asia Pacific, by Route of Administration
◦ Asia Pacific, by Type
◦ Asia Pacific, by Technology
◦ Asia Pacific, by Type of Molecule
◦ Asia Pacific, by API Peptide Type
• Eastern Europe
◦ Eastern Europe, by Country
▪ Russia
▪ Turkey
▪ Rest of Eastern Europe
◦ Eastern Europe, by Application
◦ Eastern Europe, by Route of Administration
◦ Eastern Europe, by Type
◦ Eastern Europe, by Technology
◦ Eastern Europe, by Type of Molecule
◦ Eastern Europe, by API Peptide Type
• Middle East
◦ Middle East, by Country
▪ UAE
▪ Saudi Arabia
▪ Qatar
▪ Iran
▪ Rest of Middle East
◦ Middle East, by Application
◦ Middle East, by Route of Administration
◦ Middle East, by Type
◦ Middle East, by Technology
◦ Middle East, by Type of Molecule
◦ Middle East, by API Peptide Type
• Rest of the World
◦ Rest of the World, by Country
▪ South America
▪ Africa
◦ Rest of the World, by Application
◦ Rest of the World, by Route of Administration
◦ Rest of the World, by Type
◦ Rest of the World, by Technology
◦ Rest of the World, by Type of Molecule
◦ Rest of the World, by API Peptide Type
Major Companies:
Key Players: Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Sanofi, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., Eli Lilly and Co., Bachem Holding AG, Amgen Inc.
Years Covered in the Study:
Historic Year: 2016-2017
Base Year:2018
Estimated Year: 2019
Forecast Year: 2028
Objectives of this report:
- To estimate the market size for the Peptide Therapeutics market on a regional and global basis.
- To identify major segments in the Peptide Therapeutics market and evaluate their market shares and demand.
- To provide a competitive scenario for the Peptide Therapeutics market with major developments observed by key companies in the historic years.
- To evaluate key factors governing the dynamics of the Peptide Therapeutics market with their potential gravity during the forecast period.
Reasons to Buy This Report:
- Provides niche insights for a decision about every possible segment helping in the strategic decision-making process.
- Market size estimation of the Peptide Therapeutics market on a regional and global basis.
- A unique research design for market size estimation and forecast.
- Identification of major companies operating in the market with related developments
- Exhaustive scope to cover all the possible segments helping every stakeholder in the Peptide Therapeutics market.
Customization:
This study is customized to meet your specific requirements:
- By Segment
- By Sub-segment
- By Region/Country
- Product Specific Competitive Analysis
For more information, contact: sales@quincemarketinsights.com